Loading organizations...
Loading organizations...
Drug discovery targeting protein homeostasis for autoimmune disorders.
Kezar Life Sciences has raised $73.0M across 2 funding rounds.
Kezar Life Sciences has raised $73.0M in total across 2 funding rounds.
Kezar Life Sciences has raised $73.0M in total across 2 funding rounds.
Kezar Life Sciences's investors include Bihua Chen, Morningside, AJU IB Investment, Bay City Capital, Cowen Healthcare Investments, EcoR1 Capital, Omega Funds, Pappas Ventures, Qiming Venture Partners, 9W Capital Management, Cormorant Asset Management, Onyx Pharmaceuticals.
Kezar Life Sciences has raised $73.0M across 2 funding rounds. Most recently, it raised $50.0M Series B in July 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 25, 2017 | $50.0M Series B | Bihua Chen, Morningside | AJU IB Investment, Bay City Capital, Cowen Healthcare Investments, EcoR1 Capital, Omega Funds, Pappas Ventures, Qiming Venture Partners |
| Jun 16, 2015 | $23.0M Series A | 9W Capital Management, AJU IB Investment, Cormorant Asset Management, EcoR1 Capital, Morningside, Omega Funds, Onyx Pharmaceuticals |